RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Head-to-Head Biologics Trial Shows No Difference between Abatacept and Adalimumab
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 19
SP 15
OP 16
DO 10.1177/155989771219011
UL http://mdc.sagepub.com/content/12/19/15.abstract
AB Outcomes from the Abatacept Versus Adalimumab Head-to-Head [AMPLE; NCT00929864] trial demonstrated comparable efficacy between subcutaneous abatacept and adalimumab on background methotrexate. This article discusses key efficacy and safety results from the trial.